Invite a Colleague
Feedback & Suggestions
Close




Technologies

Licensable Technology Search

Keyword Search Institution Type Category  

Technology Title Type Category
Regulation of NFkB by Reversible Acetylation
J. David Gladstone Institutes Assay HIV Therapeutics
Novel Virion-Based Fusion Assay
J. David Gladstone Institutes Assay HIV Therapeutics
Dephosphorylation of HDAC7 by Myosin Phosphatase
J. David Gladstone Institutes Assay Immunology
Methods for Changing the Level of a Toxic Protien in a Cell
J. David Gladstone Institutes Assay Neuro - OI
A Method to Visualize and Quantify Distinct Phases of Cellular Proliferation in Living Cells
J. David Gladstone Institutes Assay Neuro - OI
Specific Assay for the HIV-induced CD4 Down-modulation for the Screening of anti-HIV Drugs
University of California San Diego Assay HIV Therapeutics
Complementary Screens for the Development of Tuberculosis Drugs and Vaccines
University of California San Diego Assay Tuberculosis
Nanoparticle Fluors and Functionalization Techniques for use in Fluorescent Labeling
University of California Davis Assay Immunology
A New Tandem-Affinity Tag for Two-Step Protein Purification under Fully Denaturing Conditions
University of California Irvine Assay HIV Biology
Isolation of Biological Materials
University of California Irvine Assay HIV Biology
Blood Test that Predicts Good Prognosis In Aids
University of California Los Angeles Assay HIV Diagnostics
Cell Fusion Assay for HIV
University of California Office of President Assay HIV Therapeutics
Method And Probes for The Identification Of Microbial Genes Specifically Induced During Host Infection
University of California Santa Barbara Assay Antimicrobial
Electronic Detection Of Molecular Targets, Including Proteins, Oligonucleotides and Other Small Molecules
University of California Santa Barbara Assay Diagnostics
A Reagentless Signal-On Architecture for Electronic, Aptamer-Based Sensors via Target-Induced Strand Displacement
University of California Santa Barbara Assay HIV Therapeutics
Novel and Highly Efficient Polypeptide Display Technology
University of California Santa Barbara Assay HIV Therapeutics
Determination of Protein Fold Recognition Using Chemical Cross-linking and Mass Spectrometry
University of California San Francisco Assay Diagnostics
A Multiplexed In Vivo Assay of Small Molecule Structure Space
University of California San Francisco Assay Diagnostics
Cancer Biomarkers
University of California San Francisco Assay Cancer - OI
Characterization of Leukocyte Proportions from Whole Blood
University of California Davis Device HIV Diagnostics
Oral Based Lab-on-a-Chip ("Lollilab")
University of California Irvine Device HIV Diagnostics
Needle-free Liquid Jet Injector For Drug and Vaccine Delivery
University of California Santa Barbara Device HIV Therapeutics
Percutaneous Cancer Therapeutic Drug Delivery Device
University of California San Francisco Device Cancer - OI
A Novel Therapeutic Strategy for HIV Infection
J. David Gladstone Institutes Methodology HIV Therapeutics
Method for Inhibiting NF-KB Activation
J. David Gladstone Institutes Methodology HIV Therapeutics
Novel Strategies for the Treatment of HIV Infection
J. David Gladstone Institutes Methodology HIV Therapeutics
Selection of RNA-Binding Peptides from Combinational Libraries
J. David Gladstone Institutes Methodology HIV Therapeutics
Synthetic Peptide of Regulatory Virus Protien R (VPR) of HIV-1 and its Utilization
J. David Gladstone Institutes Methodology HIV Therapeutics
Receptors for Selective Activation of Cellular G-Protein Signaling Pathways
J. David Gladstone Institutes Methodology Neuro - OI
Method of Detecting Specific Cell Lysis
J. David Gladstone Institutes Methodology T Cell Biology
Interference with the Virus-Induced CD4 Down-Modulation as an Anti-HIV Approach
University of California San Diego Methodology HIV Therapeutics
Functional Ligand Display
University of California San Diego Methodology HIV Therapeutics
Method for Identifying Drug Targets Using Sequence Data
University of California San Diego Methodology HIV Therapeutics
Method for Tumor Targeting and Radiometal Chelate Capture
University of California Davis Methodology Cancer - OI
Novel Encoding Method for Combinatorial Libraries
University of California Davis Methodology HIV Therapeutics
Label Free Bioamplifier
University of California Davis Methodology HIV Therapeutics
Potentiation of Small Molecules for Steroids Action
University of California Davis Methodology Steroids - OI
Method for Regulating Apoptosis
University of California Davis Methodology Therapeutics
Nanostructure Enhanced X-ray Therapy (NEXT)
University of California Davis Methodology Therapeutics
Patent Portfolio for Islet Cell Coating Techniques
University of California Davis Methodology Transplant
Genomic Sequence, Diagnosis, and Treatment of Borna Disease Virus and Infection
University of California Irvine Methodology AIDS Encephalopathy
Phototherapeutic Inactivation of Ocular Viruses
University of California Irvine Methodology CMV
Position-specific Insertion Vectors
University of California Irvine Methodology HIV Biology
Position-specific Insertion Vectors And Method Of Using Same
University of California Irvine Methodology HIV Biology
Targeted, Protein-Specific Recognition, Degradation, and Elimination
University of California Irvine Methodology HIV Therapeutics
Enhancement of Host Defense Via Receptor(s) for C1q
University of California Irvine Methodology Immunology
Simplified Method for Producing a Panel Array Of Biomarkers For Detection, Prognosis and Prediction of Multiple Cancers
University of California Los Angeles Methodology Cancer - OI
Anti-inflammatory Properties of Gaba And Gaba Agonists
University of California Los Angeles Methodology Cancer - OI
Reversal of Drug Resistance in Aids-related Lymphomas
University of California Los Angeles Methodology Cancer - OI
HIV Protein Moderates Telomerase
University of California Los Angeles Methodology HIV Therapeutics
Novel Gene Therapy for Aids Using Mutated tRNAs
University of California Los Angeles Methodology HIV Therapeutics
Genomic Screening with a Chemical Nuclease
University of California Los Angeles Methodology HIV Therapeutics
Polypeptides and Antibodies Associated with HTLV
University of California Los Angeles Methodology Immunology
Immunoglobulin Superantigen Binding to GP120 From HIV
University of California Los Angeles Methodology Immunology
Restoration of Impaired Cellular Immune Function
University of California Los Angeles Methodology Immunology
Method and Composition for Treatment of Kaposi's Sarcoma
University of California Los Angeles Methodology Opportunistic Infection
Live Recombinant Tuberculosis Vaccine
University of California Los Angeles Methodology Tuberculosis
New Recombinant Tuberculosis Bcg Vaccine for Immunocompromised Patients and Others
University of California Los Angeles Methodology Tuberculosis
Novel Approach to Screening for Inhibitors of Lentivirus Replication
University of California Office of President Methodology HIV Biology
Development of Small Molecule Inhibitors or Cell- Permeable Peptides that Block HIV-1 Mediated Suppression of the Antiviral Factor APOBEC3G/CEM15
University of California Office of President Methodology HIV Therapeutics
Modulation of Immune Responses by SIRT1
University of California Office of President Methodology Immunology
Identification, Diagnosis and Therapy for Cell Death-related Diseases
University of California Santa Barbara Methodology Immunology
Modulation of B-cell Chemoattractant/Receptor Interaction as Treatment for Immune Disease
University of California San Francisco Methodology Immunology
Method for Nucleic Acid Structure-based Virtual Drug Discovery
University of California San Francisco Methodology HIV Therapeutics
Novel Components Required for M. Tuberculosis Virulence and Immunogenesis
University of California San Francisco Methodology Tuberculosis
Novel Methodologies For Vaccine Development
University of California San Francisco Methodology HIV Therapeutics
New Method for Tissue Selective Gene or Virus Expression
University of California San Francisco Methodology HIV Biology
saRNA-directed Transcriptional Activation
University of California San Francisco Methodology HIV Biology
Improving Vaccines: Increased Viral Attenuation and Fidelity
University of California San Francisco Methodology HIV Therapeutics
A Treatment for AIDS Wasting Syndrome and Potential HIV-1 Vaccine Development
University of California San Francisco Methodology HIV Therapeutics
High Throughput Screen for Modulators of the Unfolded Protein Response
University of California San Francisco Methodology HIV Therapeutics
Rationally Designed Small Molecule Inhibitors for HDAC-8
J. David Gladstone Institutes Reagent Cancer - OI
Inhibitors of APOBEC-3C that suppress HIV Mutation
J. David Gladstone Institutes Reagent HIV Therapeutics
Novel Compositions for Delivering Molecules into a Cell
J. David Gladstone Institutes Reagent HIV Therapeutics
Inhibitors of APOBEC-3C that Suppress HIV Mutation
J. David Gladstone Institutes Reagent HIV Therapeutics
Cell Surface Receptor for Filoviridae
J. David Gladstone Institutes Reagent Viral Entry
Compounds and Screens for Therapeutics against Tuberculosis and other Mycobacterial Infections
University of California San Diego Reagent Tuberculosis
Chemical Antibodies for Immunotherapy
University of California Davis Reagent Immunology
Novel Receptor-Binding Cyclic Peptides
University of California Davis Reagent Therapeutics
Ligands for Alpha-4-Beta-1 Integrin
University of California Davis Reagent Therapeutics
Amantadine Derivatives (Amantadine Analogues) for the Treatment of Hepatitis C Virus
University of California Irvine Reagent HCV
Novel and Selective Inhibitors of HIV-1 Integrase
University of California Irvine Reagent HIV Therapeutics
Novel And Selective Inhibitors Of HIV-1 Integrase
University of California Irvine Reagent HIV Therapeutics
Anti-tuberculosis Drug Targeted at Acyl-CoA Carboxylase of Mycobacterium Tuberculosis
University of California Irvine Reagent Tuberculosis
Retrocyclins: Antiviral Circular Minidefensins that Protect Against Human Immunodeficiency Virus and Herpes Simplex Viruses
University of California Los Angeles Reagent HIV Therapeutics
Use of a B Cell Superantigen Peptide As An Immunogen
University of California Los Angeles Reagent Immunology
Cell Lines for the Study Of Kaposi's Sarcoma and Smooth Muscle Cells
University of California Los Angeles Reagent Opportunistic Infection
Methionine Sulfoximine Analogs as Drug Candidates for Tuberculosis Treatment
University of California Los Angeles Reagent Tuberculosis
Novel Antisense Agent
University of California Office of President Reagent HIV Therapeutics
Peptide or Peptidomimetic Inhibitors of HIV Replication
University of California Office of President Reagent HIV Therapeutics
Identification, Purification and Characterization of Cell Lines Carrying Latent HIV
University of California Office of President Reagent HIV Therapeutics
Development of Small Molecule Inhibitors or Cell-permeable Peptides that Block HIV-1 Mediated Suppression of the Antiviral Factor APOBEC3G/CEM15
University of California Office of President Reagent HIV Therapeutics
Animal Model for the Study of HIV Infection and Replication
University of California Office of President Reagent Immunology
Lymphotoxin-beta and Lymphotoxin-beta Complexes
University of California Riverside Reagent Immunology
Family of Small Molecule Compounds that Inhibit both HIV Reverse Transcriptase and Integrase
University of California San Francisco Reagent HIV Therapeutics
Novel Anti-infective Small Molecules That Target RNA
University of California San Francisco Reagent HIV Therapeutics
Functional Mimicry by Classes of Organic Molecules
University of California San Francisco Reagent HIV Therapeutics
Cell Line Producing Fc Control Protein (Fc Portion of Human IgG)
University of California San Francisco Reagent Immunology